Australian Ocean Health announced that the company's stock price had a cumulative deviation value of more than 20% in the closing price increase for two consecutive trading days on June 9 and 10, 2025, which is an abnormal fluctuation in stock trading. After verification, there were no major changes in the information disclosed by the company in the early stages. The company did not find any undisclosed material information that may or have had a significant impact on the company's stock trading price recently. The company's current business situation is normal, there have been no major changes in the internal and external business environment, the company's controlling shareholder Aoyang Group, and Mr. Shen Xueru, the actual controller, did not trade the company's shares during the period of abnormal stock fluctuations.

Australian Ocean Health announced that the company's stock price had a cumulative deviation value of more than 20% in the closing price increase for two consecutive trading days on June 9 and 10, 2025, which is an abnormal fluctuation in stock trading. After verification, there were no major changes in the information disclosed by the company in the early stages. The company did not find any undisclosed material information that may or have had a significant impact on the company's stock trading price recently. The company's current business situation is normal, there have been no major changes in the internal and external business environment, the company's controlling shareholder Aoyang Group, and Mr. Shen Xueru, the actual controller, did not trade the company's shares during the period of abnormal stock fluctuations.